Abbott launches vaccine for children against pneumococcal bacterial infections

Abbott launches PneumoShield 14, a new pneumococcal conjugate vaccine for children over 6 weeks of age. This vaccine offers broad protection against 14 different strains of pneumococcal bacteria, which can cause severe diseases in children. It is recommended for children under 5 years of age, especially those under 2 years old.